The same unique structure that makes plastic so versatile also makes it susceptible to breaking down into harmful micro- and nanoscale particles.
The world is saturated with trillions of microscopic and nanoscopic plastic particles, some smaller than a virus, making them small enough to interfere with cellular function and even alter DNA. Researchers have found these particles in nearly every environment they've studied, from Antarctic snow to human blood.
In a new study, scientists have mapped out the molecular mechanisms behind the widespread formation of these tiny plastic fragments. Since plastic first entered the market 75 years ago, its use has become nearly universal—and so has the presence of nanoplastics.
The same properties that make plastic durable and flexible also make it susceptible to breaking down into nanoscale pieces. This breakdown is especially common in the 75-80% of plastics classified as semicrystalline polymers. The research was led by Sanat Kumar, Michael Bykhovsky, and Charo Gonzalez-Bykhovsky, professors of Chemical Engineering at Columbia Engineering.
If you look at a piece of plastic through a powerful microscope, you'll see alternating layers of hard material and soft material. In the hard layers, plastic molecules are rigidly organized in strong crystal structures. In the soft layers, the molecules lack structure and form a soft, amorphous mass.
When thousands of these layers are stacked together, they create a material that's lightweight, durable, and extremely versatile. Importantly these materials derive their unique properties through the connectivity between the soft and hard phases.
In a paper published March 28 in Nature Communications, the researchers explain how nanoplastics form. They discovered that the process begins in the soft layers, which grow weaker over time due to environmental degradation and can break off even when the plastic is not under stress. By themselves, these soft pieces break down quickly in the environment. Problems arise when the failure of a soft layer allows hard layers to break off. These crystalline fragments are the nano- and microplastics that can persist in the environment for centuries and cause significant damage in living things, including humans.
We sat down with Kumar to learn more about this work.
How does this paper contribute to our understanding of nanoplastics?
There is a lot of anecdotal evidence of nanoplastics — people have found them all over the place and seen them form — but no one had determined the mechanisms behind how they form.
What did you discover?
75% of all plastic used has sort of a brick-and-mortar structure. It's made of really thin alternating layers: hard, soft, hard, soft, and so on. We've known since the 1950s that the soft stuff is holding the hard stuff together.
What we show in the new study is how easily those soft connectors break even under quiescent conditions such as in a landfill. Once that layer fails, the hard segments have nowhere to go — they scatter into the environment.
Why is that a problem?
These pieces float around, and some end up in human bodies. The smallest pieces pass through cells and into the nucleus, where they can start messing with DNA. Nano- and microplastics, which seem to have similar sizes and shapes to asbestos, raise the potential that they could cause cancer, heart disease/stroke, and other diseases.
Is there an engineering solution to address this problem?
Our results suggest that engineering the architecture of the soft layers to be more resilient would decrease the amount of crystalline fragments that break off.
Clearly, focus needs to be placed on this point to reduce the amount of micro and nano plastics created by normal polymer degradation.
How can better understanding nanoplastics improve human health?
Only 2% of plastics are recycled, mostly because it's too expensive. But if you just throw plastic into the environment, it creates micro- and nanoplastics that look like they are going to cause health problems.
If you think about it that way, if you have to choose between the health problems that could be created by the nanoplastics vs. the cost of recycling, then maybe it's actually cheaper to recycle.
Reference: "Mechanism of quiescent nanoplastic formation from semicrystalline polymers" by Nicholas F. Mendez, Vivek Sharma, Michele Valsecchi, Vighnesh Pai, Johnny K. Lee, Linda S. Schadler, Alejandro J. Müller, Shelby Watson-Sanders, Mark Dadmun, Guruswamy Kumaraswamy and Sanat K. Kumar, 28 March 2025, Nature Communications.
DOI: 10.1038/s41467-025-58233-3
The study was funded by the U.S. National Science Foundation and the Basque Government.
News
Brazilian Tree Compounds Fight COVID-19 on Multiple Fronts
Scientists found compounds in a Brazilian tree that hit SARS-CoV-2 on multiple fronts, revealing a promising new lead in the search for COVID-19 treatments. Researchers have found that galloylquinic acids extracted from the leaves [...]
Cutting Two Amino Acids Slowed Prostate Cancer in Mice
A newly identified link between amino acid metabolism and cholesterol production may help prostate tumors adapt to hormone therapy. Prostate cancer can find ways around treatments designed to deprive tumors of the hormones they [...]
Largest-Ever Physics Survey Raises New Doubts About Our Model of the Universe
Physicists around the world remain deeply divided on key mysteries of the universe, from dark matter to quantum gravity. The standard cosmological model failed to gain majority support, and no leading theory dominated the [...]
Scientists Just Overturned a 100-Year-Old Belief About Bacteria in the Lungs
New findings raise questions about the role of microbes living in the lungs. More than 35 trillion bacteria live throughout the human body, forming microbiomes in the gut, mouth, lungs, skin, and urogenital tract. [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Novartis, Ionis drug failure spurs questions
Pelacarsen didn’t protect heart health despite lowering levels of a protein particle, “Lp(a),” in a large clinical trial — a result with important implications for cardiovascular drug research. Dive Brief: An RNA drug from [...]
New injectable treatment helps the brain rebuild after stroke
Biomedical engineers at Duke University have created an injectable biomaterial that may help the brain recover from damage left behind by an ischemic stroke. In experiments with mice, the material transformed the cavity created [...]
Scientists Discover a Hidden “Immune Organ” Inside the Skull
Researchers discovered lymph node-like immune hubs inside skull bone marrow that appear to act as rapid-response centers for the brain. For decades, the brain was thought to operate largely apart from the immune system. [...]
Engineered tRNAs and lipid nanoparticles target nonsense mutation cystic fibrosis
Researchers have developed a potential new approach for treating a form of cystic fibrosis caused by so-called nonsense mutations, combining chemically modified transfer RNAs with lipid nanoparticles designed to deliver the therapy directly to [...]
New pancreatic cancer drug carries a $39,800 monthly list price
A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. Revolution Medicines’ oral tablet daraxonrasib, branded as Rasonque, reduced the risk of [...]
Researchers Have Discovered a New Way To Reduce Chronic Nerve Pain
A cancer-linked protein called BRAF may help drive chronic nerve pain, and existing cancer drugs targeting it reduced pain sensitivity in preclinical models. Chronic nerve pain can persist long after an injury and often [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Quantum-Enabled Regenerative Health: Reimagining Wellness, Precision Health and Longevity Medicine
Introduction Healthcare is approaching a frontier where the quantum portfolio could influence not only how disease is diagnosed and treated, but how health itself is measured, modeled, predicted and preserved. Quantum computing, quantum simulation, [...]
FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD
The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option. Every day in the United States, approximately 17.5 veterans die by suicide, [...]
FDA approves breakthrough drug to treat advanced pancreatic cancer
The Food and Drug Administration (FDA) approved on Wednesday a drug that could extend the survival of those with metastatic pancreatic cancer. The drug, called daraxonrasib, will be sold under the brand name Rasonque [...]
AI Decodes a Hidden DNA Signal Linked to Disease-Causing Mutations
Machine learning identifies the likely “initiator” and enables new predictions about DNA mutations that can cause disease. Every human cell depends on tens of thousands of genes being switched on at the right time [...]















